|
CMR findings of patient population (n = 10) |
|||||
| Case No. |
Age |
LVEF (%) |
Delayed enhancement |
Medical treatment |
6 month f/u LVEF (%) |
|
|
|||||
| 1 |
33 |
32 |
Lateral, septal |
ACEI, beta blockers |
55 |
| 2 |
41 |
28 |
Lateral |
ACEI, beta blockers |
60 |
| 3 |
27 |
30 |
Lateral |
ACEI, beta blockers |
40 |
| 4 |
39 |
25 |
Lateral |
ACEI, beta blockers |
65 |
| 5 |
44 |
35 |
Lateral, septal |
ACEI, beta blockers |
60 |
| 6 |
38 |
30 |
Lateral |
ACEI, beta blockers |
40 |
| 7 |
56 |
25 |
Lateral |
ACEI, beta blockers |
30 |
| 8 |
45 |
24 |
Lateral |
ACEI, beta blockers |
55 |
| 9 |
32 |
30 |
Lateral |
ACEI, beta blockers |
35 |
| 10 |
40 |
34 |
Lateral |
ACEI, beta blockers |
58 |
|
LVEF, left ventricular ejection fraction; ACEI, angiotensin converting enzyme inhibitor. | |||||
Fallah-Rad et al. Journal of Cardiovascular Magnetic Resonance 2008 10:5 doi:10.1186/1532-429X-10-5 |
|||||